Upcoming Earnings, New Technology, Innovations, Quarterly Results, and Acquisition Updates - Research Reports on Marathon Oil, Air Products, Cameron, Whiting and Eastman

NEW YORK, October 30, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Marathon Oil Corporation (NYSE: MRO), Air Products & Chemicals Inc. (NYSE: APD), Cameron International Corporation (NYSE: CAM), Whiting Petroleum Corp. (NYSE: WLL) and Eastman Chemical Co. (NYSE: EMN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7563-100free.

--
Marathon Oil Corporation Research Reports
As per the Events and Presentations section of Marathon Oil Corporation's (Marathon Oil) official website, the Company is scheduled to host Q3 2014 earnings conference call on November 4, 2014, at 8:00 a.m. CT. Analysts polled by Bloomberg Businessweek forecast an EPS (Pre-Exceptional) of $0.74 on revenue of $2.9 billion. The full research reports on Marathon Oil are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/MRO/report.pdf

--
Air Products & Chemicals Inc. Research Reports
On October 27, 2014, Air Products & Chemicals Inc. (Air Products) reported that it has developed a new technology, which reduces the loss of vented oxygen by as much as 30% from a compact, multi-cryogenic tank system that supplies hyperbaric oxygen therapy treatment centers. According to Air Products, the new technology has been used at the Saint Peter's University Hospital's Wound Care Center and Hyperbaric Services unit in Monroe Township, New Jersey. Owing to the aforementioned technology, Saint Peter's University Hospital's Wound Care Center has used 30% less oxygen in a year. Air Products is yet to file a patent for the same. Mike Reinhardt, Medical Business Manager at Air Products, said, "The St. Peter's Monroe facility presented several challenges, including space and height restrictions. However, innovative thinking on the part of our engineering team, driven by their passion to provide solutions, led to the invention of a multi-vessel, short, low-loss system that has enabled St. Peter's to benefit from greater efficiency and optimization of its oxygen supply." The full research reports on Air Products are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/APD/report.pdf

--
Cameron International Corporation Research Reports
On October 23, 2014, Cameron International Corporation (Cameron) reported its Q3 2014 financial results. Total revenues for quarter were $2.7 billion, up 15.6% YoY. The Company reported record level of fully diluted EPS from continuing operations (excluding unusual items) of $1.17, as compared to $0.75 in Q3 2013. The Company attributed the improved results to the Drilling & Production Systems business group, which reported a 140-basis point increase in its EBITDA margin and 20.6% YoY increase in its quarterly revenue to a new record of $2.0 billion. Commenting on the results, Jack B. Moore, Chairman and CEO, said, "The Company has demonstrated sequential-quarter improvement in earnings over the course of 2014, and we believe that trend will continue in the fourth quarter, with the expectation that earnings per share from continuing operations excluding unusual items will be in a range of $1.18 to $1.23. This updated guidance reflects agreement to sell the Company's Centrifugal Compression business." The full research reports on Cameron are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/CAM/report.pdf

--
Whiting Petroleum Corp. Research Reports
On October 22, 2014, Whiting Petroleum Corp. (Whiting) announced that in relation to its proposed acquisition of Kodiak Oil & Gas Corp. (Kodiak), Kodiak has received an interim order from the British Columbia Supreme Court, which authorizes it to call and hold of a special meeting of its security holders on December 3, 2014 at 8:00 am MT to vote on matters related to the proposed acquisition. On July 13, 2014, Whiting announced an agreement to acquire Kodiak in an all-stock transaction valued at $6.0 billion, based on the closing price of Whiting on July 11, 2014, and including Kodiak's net debt of $2.2 billion as of March 31, 2014. The full research reports on Whiting are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/WLL/report.pdf

--
Eastman Chemical Co. Research Reports
On October 22, 2014, Eastman Chemical Co. (Eastman) reported that it will highlight the cleaning power of its solvent, Eastman Omnia performance at ISSA/INTERCLEAN in Orlando, Florida between November 5-7, 2014 at booth no 1840. The Company claims that Omnia, along with great cleaning ability provides extraordinary environmental safety profile and also meets CARB's LVP-VOC criteria, which facilitates its use in cleaning products designed for all 50 states. Bob Stahurski, President of Nyco Products, said, "This solvent boosts our cleaning performance. If you look at Omnia's environmental profile and its position on the CleanGredients list, it gives us differentiation among the other products in the marketplace." The full research reports on Eastman are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/EMN/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review